Skip to main navigation
Orchestra BioMed logo

Close

Investor Relations
  • Who We Are
    • Our Approach
    • Our People
    • Careers
  • Our Innovations
    • Pipeline
    • Therapeutic Areas
    • Virtue® SAB
    • BackBeat CNT™
    • FreeHold Retractors
  • Investor Relations
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Leadership Team
    • Board of Directors
    • Committee Composition
  • Financial & Filings
    • SEC Filings
    • Annual Reports and Proxy Satements
  • IR Resources
    • Email Alerts
    • Contact IR
  • Contact Us
Menu - sns
Twitter Linkedin

Investor Relations

SEC Filings

Filing date Form Description Filing Group View
Jul 27, 2022 8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
0001213900-22-041877.pdf
0001213900-22-041877.rtf
0001213900-22-041877.xls
EX-101.LAB - XBRL LABEL FILE
Jul 26, 2022 8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
0001213900-22-041497.pdf
0001213900-22-041497.rtf
0001213900-22-041497.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jul 25, 2022 4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
0001213900-22-041090.pdf
0001213900-22-041090.rtf
0001213900-22-041090.xls
Jul 18, 2022 DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
View HTML
0001140361-22-026236.pdf
0001140361-22-026236.rtf
0001140361-22-026236.xls
Jul 12, 2022 DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
View HTML
0001140361-22-025852.pdf
0001140361-22-025852.rtf
0001140361-22-025852.xls
Jul 08, 2022 425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
0001140361-22-025601.pdf
0001140361-22-025601.rtf
Jul 05, 2022 425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
0001140361-22-024894.pdf
0001140361-22-024894.rtf
0001140361-22-024894.xls
Jul 05, 2022 8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
0001140361-22-024892.pdf
0001140361-22-024892.rtf
0001140361-22-024892.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jul 05, 2022 425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
0001140361-22-025030.pdf
0001140361-22-025030.rtf
Jul 01, 2022 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
View HTML
0001140361-22-024824.pdf
0001140361-22-024824.rtf
0001140361-22-024824.xls

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Current page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • …
  • Next page Next ›
  • Last page Last »
Displaying 71 - 80 of 124 results

Data provided by Kaleidoscope.

Orchestra BioMed logo
  • Footerlink - who we are

    Who We Are Our Approach Our People Careers
  • Footerlink - our innovations

    Our Innovations Pipeline Therapeutic Areas Virtue® SAB BackBeat CNT™ FreeHold Retractors
  • Footerlink - news & events

    Investor Relations Overview News & Events Stock Information Corporate Governance Financial & Filings IR Resources
  • Footerlink - contact us

    Contact Us
Menu - sns
Twitter Linkedin

© 2023 Orchestra BioMed Inc. Virtue®, BackBeat CNT™ FreeHold Duo®, FreeHold Trio® and Orchestra BioMed™ are trademarks of Orchestra BioMed.
All other trademarks are trademarks of their respective owners.
SM-0020 Rev 01

Btn - disclaimer

Disclaimer